Cargando…

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?

Detalles Bibliográficos
Autor principal:	Caverly, Lindsay J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667808/ https://www.ncbi.nlm.nih.gov/pubmed/36318079 http://dx.doi.org/10.1513/AnnalsATS.202208-703ED

Ejemplares similares

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations
por: Waters, Valerie
Publicado: (2021)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Identifying the Risk of Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Step Forward
por: Vancheri, Carlo, et al.
Publicado: (2022)

Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis
por: Breen, Paul, et al.
Publicado: (2022)

The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Kampouras, Asterios, et al.
Publicado: (2021)

One Center’s Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation
por: Muirhead, Corinne A., et al.
Publicado: (2016)

The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis
por: Al-Aloul, Mohamed, et al.
Publicado: (2019)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians
por: Currie, Grace, et al.
Publicado: (2021)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms
por: Kreuter, Michael, et al.
Publicado: (2020)

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis
por: Wagner, Brandie D., et al.
Publicado: (2021)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
por: Velino, Cecilia, et al.
Publicado: (2019)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
por: Caverly, Lindsay J., et al.
Publicado: (2021)

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
por: Wells, J. Michael, et al.
Publicado: (2016)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults
por: Esquivel, Marc, et al.
Publicado: (2021)

Nutrition in Cystic Fibrosis: as important as the management of pulmonary disease
por: Adde, Fabíola Villac
Publicado: (2015)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis
por: Meyer, Viviane Mauro Correa, et al.
Publicado: (2020)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
por: VanDevanter, Donald R, et al.
Publicado: (2010)

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
por: Devereux, Graham, et al.
Publicado: (2020)

Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better
por: Oates, Gabriela R., et al.
Publicado: (2021)

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
por: Pedemonte, Nicoletta
Publicado: (2020)

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
por: Solomon, George M., et al.
Publicado: (2013)

Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
por: Wojewodka, Gabriella, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0tnk9mgi741kme99i0let581b1